Cargando…
Safety and Efficacy of a MEURI Program for the Use of High Dose Ivermectin in COVID-19 Patients
BACKGROUND: In the absence of antiviral alternatives, interventions under research for COVID-19 might be offered following guidelines from WHO for monitored emergency use of unregistered and experimental interventions (MEURI). Ivermectin is among several drugs explored for its role against SARS-CoV-...
Autores principales: | Mayer, Marcos Alejandro, Krolewiecki, Alejandro, Ferrero, Alejandro, Bocchio, Marcelo, Barbero, Juan, Miguel, Marcos, Paladini, Ariel, Delgado, Carlos, Ojeda, Juan Ramón, Elorza, Claudia, Bertone, Ana, Fleitas, Pedro Emanuel, Vera, Gustavo, Kohan, Mario Rubén |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902036/ https://www.ncbi.nlm.nih.gov/pubmed/35273939 http://dx.doi.org/10.3389/fpubh.2022.813378 |
Ejemplares similares
-
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
por: Camprubí, Daniel, et al.
Publicado: (2020) -
Correction: Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
por: Camprubí, Daniel, et al.
Publicado: (2022) -
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
por: Krolewiecki, Alejandro, et al.
Publicado: (2021) -
Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Sequence Randomized, Crossover Clinical Trial in Healthy Volunteers
por: Algorta, Jaime, et al.
Publicado: (2022) -
Mapping the global distribution of Strongyloides stercoralis and hookworms by ecological niche modeling
por: Fleitas, Pedro Emanuel, et al.
Publicado: (2022)